FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1964273 · Received January 19, 2011

Report

Report Number
2024168-2011-00378
Event Type
Injury
Date Received
January 19, 2011
Date of Event
January 20, 2010
Report Date
December 25, 2010
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE 2.5 X 12 MM XIENCE V (1009545-12, 8062361) ON THE INITITAL MEDWATCH IS BEING REPORTED UNDER A SEPARATE MEDWATCH REPORT NUMBER.

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. ANGINA, RESTENOSIS, ADDITIONAL THERAPY/NONSURGICAL TREATMENT, AND HOSPITALIZATION ARE FORESEEABLE EVENTS. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE OR DESIGN.

Description of Event or Problem · 1

IT WAS REPORTED VIA A TRIAL THAT APPROXIMATELY 14 MONTHS POST XIENCE STENT IMPLANTATION IN THE MID LEFT ANTERIOR DESCENDING ARTERY THE PATIENT EXPERIENCED EXERTIONAL ANGINA. THE PATIENT UNDERWENT A (B)(6) WHICH WAS POSITIVE. ON (B)(6) 2010 THREE STENTS WERE PLACED IN THE INDEX TARGET LESION DUE TO 100% IN-STENT RESTENOSIS. THE PATIENT'S CONDITION RESOLVED ON (B)(6) 2010. THERE WAS NO ADVERSE PATIENT SEQUELA. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.

Description of Event or Problem · 1

SUBSEQUENT TO THE INITIAL MEDWATCH REPORT, ADDITIONAL INFORMATION RECEIVED INDICATING THAT BOTH INDEX PROCEDURE STENTS HAD IN-STENT RESTENOSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 8060661

Patients

Seq Age Sex Outcome Treatment
1 50 YR Hospitalization| R STENT: 2.5 X 12 XIENCE V